Trial Profile
An open-label study to evaluate the pharmacokinetics, safety and tolerability of a single dose of ceftobiprole in paediatric patients requiring systemic antibiotics
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 12 May 2016
Price :
$35
*
At a glance
- Drugs Ceftobiprole medocaril (Primary)
- Indications Community-acquired pneumonia
- Focus Pharmacokinetics
- 12 May 2016 New trial record
- 12 Apr 2016 Results presented at the 26th European Congress of Clinical Microbiology and Infectious Diseases